LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 136 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $310,000 | -13.4% | 36,202 | 0.0% | 0.01% | -12.5% |
Q4 2017 | $358,000 | -19.6% | 36,202 | 0.0% | 0.01% | -20.0% |
Q3 2017 | $445,000 | -25.3% | 36,202 | 0.0% | 0.01% | -23.1% |
Q2 2017 | $596,000 | +14.8% | 36,202 | 0.0% | 0.01% | +8.3% |
Q1 2017 | $519,000 | – | 36,202 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |